In 2007, cardiologist Jay Yadav sued the Cleveland Clinic, saying he was unjustly fired by the institution for allegedly failing to stick to the clinic's conflict of interest policies. Yadav developed a device to prevent vascular blockages and sold it to a company called Angioguard, which compensated him with stock. After the company was purchased by Johnson & Johnson unit Cordis, Yadav was entitled to deferred payments, and that compensation was the subject of his disagreement with the clinic. Now the parties have settled. A joint statement says the clinic acknowledges that Yadav did disclose an interest in the sale of Angioguard and that an independent review "concluded that the integrity of Dr. Yadav's research regarding Angioguard/Cordis was not compromised by his financial relationships."
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
